Even if studies are focused in metastatic melanoma (MM) specimens and for the most abundant BRAF and NRAS mutations, the prognostic significance in MM is less understood and, in some cases, controversial (8–10). This evidence concerns the gene NRAS and Miyoshi myopathy.